Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cell-mediated Immune Responses

Cell-mediated Immune Responses

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Bone Marrow Sampling and Transplants

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Tissue Transplantation

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

Regulation of Hematopoietic Stem Cells

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

p97 Inhibition Synergistically Enhances Hypomethylating Therapy through Targeting of PLK1 in Acute Myeloid Leukemia.

Cancer research communications·2026

Same author

Evolving target: A 16-year progressive framework for shifting the rubric of scientific publishing toward transparency, artificial intelligence, and the Economic Impact Factor for impact that matters.

World journal of stem cells·2026

Same author

Rethinking p16, p53, and HPV in HNCSCC through lessons from glioblastoma subclonal evolution toward patient-centric N-of-1 single-cell RNA sequencing paradigm.

World journal of clinical cases·2025

Same author

DeepDeconUQ estimates malignant cell fraction prediction intervals in bulk RNA-seq tissue.

PLoS computational biology·2025

Same author

Enhance the therapeutic efficacy of human umbilical cord-derived mesenchymal stem cells in prevention of acute graft-versus-host disease through CRISPLD2 modulation.

Stem cell research & therapy·2025

Same author

A 6-tsRNA signature for early detection, treatment response monitoring, and prognosis prediction in diffuse large B cell lymphoma.

Blood cancer journal·2025

Same journal

Sclerostin silencing in human umbilical cord mesenchymal stem cells enhances bone regeneration <i>via</i> Wnt pathway activation.

World journal of stem cells·2026

Same journal

Targeting mitochondrial quality control in osteoarthritis with GrpE-like 1-loaded synovial mesenchymal stromal/stem cell small extracellular vesicles.

World journal of stem cells·2026

Same journal

Epiregulin enhances periodontal tissue regeneration by promoting bone marrow mesenchymal stem cell functions under inflammatory niches.

World journal of stem cells·2026

Same journal

Correction to "Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis".

World journal of stem cells·2026

Same journal

GATA2 deficiency exacerbates chronic liver injury <i>via</i> disrupting hepatocyte death-regeneration balance: Clinical, histopathological, and molecular evidence.

World journal of stem cells·2026

Same journal

Therapeutic applications of mesenchymal stem cell-derived extracellular vesicles in pain management: A narrative review of emerging evidence and future directions.

World journal of stem cells·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 7, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Twisting immune responses for allogeneic stem cell therapy.

Shengwen Calvin Li¹, Jiang F Zhong

¹Shengwen Calvin Li, CHOC Children's Hospital Research Institute, University of California Irvine, 455 South Main Street, Orange, California, CA 92868, United States.

World Journal of Stem Cells

|October 27, 2010

Summary

This summary is machine-generated.

This study introduces a novel strategy to prevent immune rejection of stem cell therapies by inducing specific donor antigen tolerance. The method restores thymic function and introduces donor hematopoietic stem cells to the thymus.

Keywords:

Allogeneic grafts Immune response Stem cell therapy

More Related Videos

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Related Experiment Videos

Last Updated: Jun 7, 2026

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Development of Stem Cell-derived Antigen-specific Regulatory T Cells Against Autoimmunity

Published on: November 8, 2016

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Area of Science:

Regenerative Medicine
Immunology
Transplantation Science

Background:

Allogeneic graft rejection by the host immune system hinders the clinical application of stem cell-derived tissues and organs.
Mismatches in human leukocyte class I and minor histocompatibility antigens are primary causes of graft-versus-host disease.
Current immunosuppressive drugs have significant side effects.

Purpose of the Study:

To present an emerging strategy for manipulating central immune tolerance to donor cells and tissues.
To detail a two-stage approach for inducing specific tolerance to allogeneic grafts.

Main Methods:

Stage 1: Restoration of thymic function in adult patients using luteinizing hormone-releasing hormone agonists (LHRH-A), keratinocyte growth factor (KGF), interleukin 7 (IL-7), and FMS-like tyrosine kinase 3 (FLT3).
Stage 2: Direct injection of donor hematopoietic stem cells and progenitors into the restored thymus to introduce donor antigens.
Utilizing hematopoietic stem cells for their preferential access to the thymus.

Main Results:

The described strategy aims to induce specific tolerance to donor cells, circumventing the need for broad immunosuppression.
Review of clinical cases supports the feasibility and potential efficacy of this novel tolerance induction method.

Conclusions:

This innovative approach offers a promising alternative to traditional immunosuppression for stem cell-based therapies.
Achieving specific immune tolerance is crucial for the successful clinical translation of embryonic stem cell-derived medicines.